{"id":"W2117050193","doi":"10.1200/jco.2005.51.008","title":"Combining Gemcitabine and Capecitabine in Patients With Advanced Biliary Cancer: A Phase II Trial","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"American Society of Clinical Oncology","keywords":"Medicine; Capecitabine; Gemcitabine; Internal medicine; Gallbladder cancer; Regimen; Gastroenterology; Chemotherapy; Neutropenia; Cancer; Oncology; Surgery; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001257379,0.001108872,0.002039681,0.0003768095,0.000314824,0.0009327653,0.0005871612,0.001218386,0.002894083],"category_scores_gemma":[0.001149722,0.0003877128,0.00109806,0.0005582921,0.0006669279,0.0005901179,0.0003725164,0.002351964,0.0004755111],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008207627,"about_ca_system_score_gemma":0.001315235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005812249,"about_ca_topic_score_gemma":0.001461425,"domain_scores_codex":[0.9996026,0.0002239888,0.00002772505,0.00005266857,0.00003170426,0.00006133578],"domain_scores_gemma":[0.9992431,0.0001396365,0.0001729667,0.00003978628,0.00003344543,0.0003710114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8457281,0.02431939,0.00853377,0.001408149,0.001823867,0.0003600979,0.0001771665,0.002102712,0.009671541,0.0001586,0.003096289,0.1026202],"study_design_scores_gemma":[0.8522421,0.1375995,0.005800683,0.0000651878,0.0004221865,0.000268432,0.00003073368,0.0008938802,0.0008214116,0.0001089571,0.00173189,0.00001496381],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9900396,0.005506646,0.0002759625,0.0007039313,0.0001223042,0.001579351,0.0003217286,0.00005697145,0.00139347],"genre_scores_gemma":[0.9885971,0.003880292,0.001303889,0.001134977,0.0002561204,0.002436451,0.001010586,0.00001630645,0.001364341],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002894083,"threshold_uncertainty_score":0.009681642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06095882156879692,"score_gpt":0.4316245179837428,"score_spread":0.3706656964149459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}